{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:56:40Z","timestamp":1790402200823,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chemistry Central Journal"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1752-153x-7-23","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T16:17:00Z","timestamp":1359994620000},"source":"Crossref","is-referenced-by-count":6,"title":["Computational analysis and predictive modeling of polymorph descriptors"],"prefix":"10.1186","volume":"7","author":[{"given":"Yugyung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Jana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathri","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,4]]},"reference":[{"key":"550_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev.biophys.36.040306.132550","volume":"36","author":"MK Gilson","year":"2007","unstructured":"Gilson MK, Zhou HX: Calculation of protein-ligand binding affinities. Annu Rev Biophys Biomol Struct. 2007, 36: 21-42. 10.1146\/annurev.biophys.36.040306.132550.","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"550_CR2","doi-asserted-by":"publisher","first-page":"e1002037","DOI":"10.1371\/journal.pcbi.1002037","volume":"7","author":"L Xie","year":"2011","unstructured":"Xie L, Evangelidis T, Bourne PE: Drug discovery using chemical systems biology: weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir. PLoS Comput Biol. 2011, 7: e1002037-10.1371\/journal.pcbi.1002037.","journal-title":"PLoS Comput Biol"},{"key":"550_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1023\/A:1022359300826","volume":"20","author":"K Horie","year":"2003","unstructured":"Horie K, Tang F, Borchardt RT: Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter. Pharm Res. 2003, 20: 161-168. 10.1023\/A:1022359300826.","journal-title":"Pharm Res"},{"key":"550_CR4","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nrd2082","volume":"5","author":"RA Copeland","year":"2006","unstructured":"Copeland RA, Pompliano DL, Meek TD: Drug-target residence time and its implications for lead optimization. Nat Rev Drug Discov. 2006, 5: 730-739. 10.1038\/nrd2082.","journal-title":"Nat Rev Drug Discov"},{"key":"550_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cbpa.2010.06.176","volume":"14","author":"H Lu","year":"2010","unstructured":"Lu H, Tonge PJ: Drug-target residence time: critical information for lead optimization. Curr Opin Chem Biol. 2010, 14: 467-474. 10.1016\/j.cbpa.2010.06.176.","journal-title":"Curr Opin Chem Biol"},{"issue":"6","key":"550_CR6","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1111\/j.1476-5381.2012.01897.x","volume":"166","author":"D Guo","year":"2012","unstructured":"Guo D, Mulder-Krieger T, Ijzerman AP, Heitman LH: Functional efficacy of adenosine A(2A) receptor agonists is positively correlated to their receptor residence time. Br J Pharmacol. 2012, 166 (6): 1846-1859. 10.1111\/j.1476-5381.2012.01897.x.","journal-title":"Br J Pharmacol"},{"key":"550_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s11095-010-0065-2","volume":"27","author":"XH Ma","year":"2010","unstructured":"Ma XH, Shi Z, Tan C, Jiang Y, Go ML, et al: In-silico approaches to multi-target drug discovery: computer aided multi-target drug design, multi-target virtual screening. Pharm Res. 2010, 27: 739-749. 10.1007\/s11095-010-0065-2.","journal-title":"Pharm Res"},{"key":"550_CR8","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1007\/s11095-009-9896-0","volume":"26","author":"P Matsson","year":"2009","unstructured":"Matsson P, Pedersen JM, Norinder U, Bergstrom CA, Artursson P: Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs. Pharm Res. 2009, 26: 1816-1831. 10.1007\/s11095-009-9896-0.","journal-title":"Pharm Res"},{"key":"550_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd3028","volume":"9","author":"KM Giacomini","year":"2010","unstructured":"Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, et al: Membrane transporters in drug development. Nat Rev Drug Discov. 2010, 9: 215-236. 10.1038\/nrd3028.","journal-title":"Nat Rev Drug Discov"},{"key":"550_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","volume":"42","author":"JH Lin","year":"2003","unstructured":"Lin JH, Yamazaki M: Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet. 2003, 42: 59-98. 10.2165\/00003088-200342010-00003.","journal-title":"Clin Pharmacokinet"},{"key":"550_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1124\/pr.55.3.1","volume":"55","author":"N Mizuno","year":"2003","unstructured":"Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y: Impact of drug transporter studies on drug discovery and development. Pharmacol Rev. 2003, 55: 425-461. 10.1124\/pr.55.3.1.","journal-title":"Pharmacol Rev"},{"key":"550_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0378-1119(96)00633-6","volume":"185","author":"JM Croop","year":"1997","unstructured":"Croop JM, Tiller GE, Fletcher JA, Lux ML, Raab E, et al: Isolation and characterization of a mammalian homolog of the drosophila white gene. Gene. 1997, 185: 77-85. 10.1016\/S0378-1119(96)00633-6.","journal-title":"Gene"},{"key":"550_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4161\/cbt.1.4.25","volume":"1","author":"JD Allen","year":"2002","unstructured":"Allen JD, Schinkel AH: Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP\/ABCG2). Mol Cancer Ther. 2002, 1: 427-434. 10.4161\/cbt.1.4.25.","journal-title":"Mol Cancer Ther"},{"key":"550_CR14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1023\/A:1012879205914","volume":"33","author":"SE Bates","year":"2001","unstructured":"Bates SE, Robey R, Miyake K, Rao K, Ross DD, et al: The role of half-transporters in multidrug resistance. J Bioenerg Biomembr. 2001, 33: 503-511. 10.1023\/A:1012879205914.","journal-title":"J Bioenerg Biomembr"},{"issue":"Pt 11","key":"550_CR15","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1242\/jcs.113.11.2011","volume":"113","author":"T Litman","year":"2000","unstructured":"Litman T, Brangi M, Hudson E, Fetsch P, Abati A, et al: The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J Cell Sci. 2000, 113 (Pt 11): 2011-2021.","journal-title":"J Cell Sci"},{"key":"550_CR16","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/ijc.23677","volume":"123","author":"C Lemos","year":"2008","unstructured":"Lemos C, Kathmann I, Giovannetti E, Dekker H, Scheffer GL, et al: Folate deprivation induces BCRP (ABCG2) expression and mitoxantrone resistance in Caco-2 cells. Int J Cancer. 2008, 123: 1712-1720. 10.1002\/ijc.23677.","journal-title":"Int J Cancer"},{"key":"550_CR17","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1158\/1535-7163.MCT-06-0339","volume":"5","author":"JA Seamon","year":"2006","unstructured":"Seamon JA, Rugg CA, Emanuel S, Calcagno AM, Ambudkar SV, et al: Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase\/Aurora kinase inhibitor. Mol Cancer Ther. 2006, 5: 2459-2467. 10.1158\/1535-7163.MCT-06-0339.","journal-title":"Mol Cancer Ther"},{"key":"550_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2133\/dmpk.18.194","volume":"18","author":"T Ishikawa","year":"2003","unstructured":"Ishikawa T, Kasamatsu S, Hagiwara Y, Mitomo H, Kato R, et al: Expression and functional characterization of human ABC transporter ABCG2 variants in insect cells. Drug Metab Pharmacokinet. 2003, 18: 194-202. 10.2133\/dmpk.18.194.","journal-title":"Drug Metab Pharmacokinet"},{"key":"550_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1042\/bj20030150","volume":"373","author":"H Mitomo","year":"2003","unstructured":"Mitomo H, Kato R, Ito A, Kasamatsu S, Ikegami Y, et al: A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport. Biochem J. 2003, 373: 767-774. 10.1042\/BJ20030150.","journal-title":"Biochem J"},{"key":"550_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0005-2736(01)00308-X","volume":"1512","author":"RW Robey","year":"2001","unstructured":"Robey RW, Honjo Y, van de Laar A, Miyake K, Regis JT, et al: A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2). Biochim Biophys Acta. 2001, 1512: 171-182. 10.1016\/S0005-2736(01)00308-X.","journal-title":"Biochim Biophys Acta"},{"key":"550_CR21","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1023\/B:PHAM.0000045245.21637.d4","volume":"21","author":"C Kondo","year":"2004","unstructured":"Kondo C, Suzuki H, Itoda M, Ozawa S, Sawada J, et al: Functional analysis of SNPs variants of BCRP\/ABCG2. Pharm Res. 2004, 21: 1895-1903.","journal-title":"Pharm Res"},{"key":"550_CR22","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1007\/s11095-008-9537-z","volume":"25","author":"Q Mao","year":"2008","unstructured":"Mao Q: BCRP\/ABCG2 in the placenta: expression, function and regulation. Pharm Res. 2008, 25: 1244-1255. 10.1007\/s11095-008-9537-z.","journal-title":"Pharm Res"},{"key":"550_CR23","doi-asserted-by":"crossref","first-page":"19858","DOI":"10.1016\/S0021-9258(18)55070-5","volume":"266","author":"JP Jaffrezou","year":"1991","unstructured":"Jaffrezou JP, Herbert JM, Levade T, Gau MN, Chatelain P, et al: Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein. J Biol Chem. 1991, 266: 19858-19864.","journal-title":"J Biol Chem"},{"key":"550_CR24","first-page":"105","volume":"2","author":"Y Sugimoto","year":"2003","unstructured":"Sugimoto Y, Tsukahara S, Imai Y, Ueda K, Tsuruo T: Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists. Mol Cancer Ther. 2003, 2: 105-112.","journal-title":"Mol Cancer Ther"},{"key":"550_CR25","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1002\/jps.20963","volume":"96","author":"A Gupta","year":"2007","unstructured":"Gupta A, Unadkat JD, Mao Q: Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP). J Pharm Sci. 2007, 96: 3226-3235. 10.1002\/jps.20963.","journal-title":"J Pharm Sci"},{"key":"550_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1021\/mp049952s","volume":"1","author":"R Jain","year":"2004","unstructured":"Jain R, Majumdar S, Nashed Y, Pal D, Mitra AK: Circumventing P-glycoprotein-mediated cellular efflux of quinidine by prodrug derivatization. Mol Pharm. 2004, 1: 290-299. 10.1021\/mp049952s.","journal-title":"Mol Pharm"},{"key":"550_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1124\/jpet.107.124768","volume":"323","author":"P Matsson","year":"2007","unstructured":"Matsson P, Englund G, Ahlin G, Bergstrom CA, Norinder U, et al: A global drug inhibition pattern for the human ATP-binding cassette transporter breast cancer resistance protein (ABCG2). J Pharmacol Exp Ther. 2007, 323: 19-30. 10.1124\/jpet.107.124768.","journal-title":"J Pharmacol Exp Ther"},{"key":"550_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4161\/cbt.1.4.20","volume":"1","author":"JD Allen","year":"2002","unstructured":"Allen JD, van Loevezijn A, Lakhai JM, van der Valk M, van Tellingen O, et al: Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C. Mol Cancer Ther. 2002, 1: 417-425. 10.4161\/cbt.1.4.22.","journal-title":"Mol Cancer Ther"},{"key":"550_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1248\/cpb.28.245","volume":"28","author":"M Yamazaki","year":"1980","unstructured":"Yamazaki M, Fujimoto H, Kawasaki T: Chemistry of tremorogenic metabolites. I. Fumitremorgin a from Aspergillus fumigatus. Chem Pharm Bull. 1980, 28: 245-254. 10.1248\/cpb.28.245.","journal-title":"Chem Pharm Bull"},{"key":"550_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/ptr.828","volume":"16","author":"JS Choi","year":"2002","unstructured":"Choi JS, Chung HY, Kang SS, Jung MJ, Kim JW, et al: The structure-activity relationship of flavonoids as scavengers of peroxynitrite. Phytother Res. 2002, 16: 232-235. 10.1002\/ptr.828.","journal-title":"Phytother Res"},{"key":"550_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0166-1280(01)00799-0","volume":"583","author":"S Erkoc","year":"2002","unstructured":"Erkoc S, Yilmazer M, Erkoc F: Structural and electronic properties of xanthohumol metabolite. J Mol Struct (THEOCHEM). 2002, 583: 169-172. 10.1016\/S0166-1280(01)00799-0.","journal-title":"J Mol Struct (THEOCHEM)"},{"key":"550_CR32","doi-asserted-by":"publisher","first-page":"re9","DOI":"10.1126\/scisignal.2100re9","volume":"2","author":"J Roy","year":"2009","unstructured":"Roy J, Cyert MS: Cracking the phosphatase code: docking interactions determine substrate specificity. Sci Signal. 2009, 2: re9-10.1126\/scisignal.2100re9.","journal-title":"Sci Signal"},{"key":"550_CR33","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nbt0605-639","volume":"23","author":"MA Branca","year":"2005","unstructured":"Branca MA: Multi-kinase inhibitors create buzz at ASCO. Nat Biotechnol. 2005, 23: 639-10.1038\/nbt0605-639.","journal-title":"Nat Biotechnol"},{"key":"550_CR34","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-10-0460","volume":"70","author":"S Iadevaia","year":"2010","unstructured":"Iadevaia S, Lu Y, Morales FC, Mills GB, Ram PT: Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis. Cancer Res. 2010, 70: 6704-6714. 10.1158\/0008-5472.CAN-10-0460.","journal-title":"Cancer Res"},{"key":"550_CR35","doi-asserted-by":"publisher","first-page":"e1000938","DOI":"10.1371\/journal.pcbi.1000938","volume":"6","author":"RL Chang","year":"2010","unstructured":"Chang RL, Xie L, Bourne PE, Palsson BO: Drug off-target effects predicted using structural analysis in the context of a metabolic network model. PLoS Comput Biol. 2010, 6: e1000938-10.1371\/journal.pcbi.1000938.","journal-title":"PLoS Comput Biol"},{"key":"550_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/bib\/bbl043","volume":"7","author":"D Gilbert","year":"2006","unstructured":"Gilbert D, Fuss H, Gu X, Orton R, Robinson S, et al: Computational methodologies for modelling, analysis and simulation of signalling networks. Brief Bioinform. 2006, 7: 339-353. 10.1093\/bib\/bbl043.","journal-title":"Brief Bioinform"},{"key":"550_CR37","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1073\/pnas.0909222107","volume":"107","author":"J Kang","year":"2010","unstructured":"Kang J, Hwang JU, Lee M, Kim YY, Assmann SM, et al: PDR-type ABC transporter mediates cellular uptake of the phytohormone abscisic acid. Proc Natl Acad Sci USA. 2010, 107: 2355-2360. 10.1073\/pnas.0909222107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"550_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","volume":"55","author":"AH Schinkel","year":"2003","unstructured":"Schinkel AH, Jonker JW: Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev. 2003, 55: 3-29. 10.1016\/S0169-409X(02)00169-2.","journal-title":"Adv Drug Deliv Rev"},{"key":"550_CR39","doi-asserted-by":"crossref","first-page":"e13529","DOI":"10.1200\/jco.2009.27.15_suppl.e13529","volume":"27","author":"AKT Bharthuar","year":"2009","unstructured":"Bharthuar AKT, Haas KN, Mashtare T, Black J, Baer M, Yang G, Khushalani N, Iyer RV: Expression of breast cancer resistance protein (BCRP) in esophageal cancers (EC). J Clin Oncol. 2009, 27: e13529-","journal-title":"J Clin Oncol"},{"key":"550_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000097800","volume":"74","author":"C Zimmermann","year":"2006","unstructured":"Zimmermann C, Hruz P, Gutmann H, Terracciano L, Beuers U, et al: Decreased expression of breast cancer resistance protein in the duodenum in patients with obstructive cholestasis. Digestion. 2006, 74: 101-108. 10.1159\/000097800.","journal-title":"Digestion"},{"key":"550_CR41","first-page":"1137","volume":"297","author":"M Tanabe","year":"2001","unstructured":"Tanabe M, Ieiri I, Nagata N, Inoue K, Ito S, et al: Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther. 2001, 297: 1137-1143.","journal-title":"J Pharmacol Exp Ther"},{"key":"550_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cellimm.2007.02.007","volume":"244","author":"DJ Erdelyi","year":"2006","unstructured":"Erdelyi DJ, Kamory E, Zalka A, Semsei AF, Csokay B, et al: The role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, a retrospective study in childhood acute lymphoblastic leukaemia. Cell Immunol. 2006, 244: 121-124. 10.1016\/j.cellimm.2007.02.007.","journal-title":"Cell Immunol"},{"key":"550_CR43","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/sj.tpj.6500099","volume":"2","author":"RL Roberts","year":"2002","unstructured":"Roberts RL, Joyce PR, Mulder RT, Begg EJ, Kennedy MA: A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression. Pharmacogenomics J. 2002, 2: 191-196. 10.1038\/sj.tpj.6500099.","journal-title":"Pharmacogenomics J"},{"key":"550_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1465-9921-6-59","volume":"6","author":"M Deen","year":"2005","unstructured":"Deen M, Vries EG, Timens W, Scheper RJ, Timmer-Bosscha H, et al: ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res. 2005, 6: 59-10.1186\/1465-9921-6-59.","journal-title":"Respir Res"},{"key":"550_CR45","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00228-005-0926-5","volume":"61","author":"M Kurzawski","year":"2005","unstructured":"Kurzawski M, Drozdzik M, Suchy J, Kurzawski G, Bialecka M, et al: Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients. Eur J Clin Pharmacol. 2005, 61: 389-394. 10.1007\/s00228-005-0926-5.","journal-title":"Eur J Clin Pharmacol"},{"key":"550_CR46","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/jac\/dkl474","volume":"59","author":"J Weiss","year":"2007","unstructured":"Weiss J, Rose J, Storch CH, Ketabi-Kiyanvash N, Sauer A, et al: Modulation of human BCRP (ABCG2) activity by anti-HIV drugs. J Antimicrob Chemother. 2007, 59: 238-245.","journal-title":"J Antimicrob Chemother"},{"key":"550_CR47","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1124\/dmd.109.030791","volume":"38","author":"EK Pollex","year":"2010","unstructured":"Pollex EK, Anger G, Hutson J, Koren G, Piquette-Miller M: Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A\/Q141K BCRP single-nucleotide polymorphism. Drug Metab Dispos. 2010, 38: 740-744. 10.1124\/dmd.109.030791.","journal-title":"Drug Metab Dispos"},{"key":"550_CR48","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/carcin\/bgm113","volume":"28","author":"LL Hu","year":"2007","unstructured":"Hu LL, Wang XX, Chen X, Chang J, Li C, et al: BCRP gene polymorphisms are associated with susceptibility and survival of diffuse large B-cell lymphoma. Carcinogenesis. 2007, 28: 1740-1744. 10.1093\/carcin\/bgm113.","journal-title":"Carcinogenesis"},{"key":"550_CR49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1124\/dmd.106.012302","volume":"35","author":"SS Lee","year":"2007","unstructured":"Lee SS, Jeong HE, Yi JM, Jung HJ, Jang JE, et al: Identification and functional assessment of BCRP polymorphisms in a Korean population. Drug Metab Dispos. 2007, 35: 623-632. 10.1124\/dmd.106.012302.","journal-title":"Drug Metab Dispos"},{"key":"550_CR50","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.tips.2009.07.004","volume":"30","author":"J Mestres","year":"2009","unstructured":"Mestres J, Gregori-Puigjane E: Conciliating binding efficiency and polypharmacology. Trends Pharmacol Sci. 2009, 30: 470-474. 10.1016\/j.tips.2009.07.004.","journal-title":"Trends Pharmacol Sci"},{"key":"550_CR51","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ab.2010.02.034","volume":"401","author":"R Moaddel","year":"2010","unstructured":"Moaddel R, Bighi F, Yamaguchi R, Patel S, Ravichandran S, et al: Stereoselective binding of chiral ligands to single nucleotide polymorphisms of the human organic cation transporter-1 determined using cellular membrane affinity chromatography. Anal Biochem. 2010, 401: 148-153. 10.1016\/j.ab.2010.02.034.","journal-title":"Anal Biochem"},{"issue":"(21","key":"550_CR52","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","volume":"72","author":"J Murai","year":"2012","unstructured":"Murai J, Huang SYN, Das BB, Renaud A, Zhang Y, Doroshow JH, Ji J, Takeda S, Pommier Y: Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. Cancer Res. 2012, 72 ((21): 5588-","journal-title":"Cancer Res"},{"key":"550_CR53","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1124\/mol.109.056192","volume":"76","author":"JF Deeken","year":"2009","unstructured":"Deeken JF, Robey RW, Shukla S, Steadman K, Chakraborty AR, et al: Identification of compounds that correlate with ABCG2 transporter function in the national cancer institute anticancer drug screen. Mol Pharmacol. 2009, 76: 946-956. 10.1124\/mol.109.056192.","journal-title":"Mol Pharmacol"},{"key":"550_CR54","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.biomaterials.2009.09.058","volume":"31","author":"JW Yoo","year":"2010","unstructured":"Yoo JW, Choe ES, Ahn SM, Lee CH: Pharmacological activity and protein phosphorylation caused by nitric oxide-releasing microparticles. Biomaterials. 2010, 31: 552-558. 10.1016\/j.biomaterials.2009.09.058.","journal-title":"Biomaterials"},{"key":"550_CR55","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","volume":"175","author":"P Artursson","year":"1991","unstructured":"Artursson P, Karlsson J: Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Comm. 1991, 175: 880-885. 10.1016\/0006-291X(91)91647-U.","journal-title":"Biochem Biophys Res Comm"},{"key":"550_CR56","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.dental.2004.08.004","volume":"21","author":"AJ Holder","year":"2005","unstructured":"Holder AJ, Ye L, Yourtee DM, Agarwal A, Eick JD, et al: An application of the QM-QSAR method to predict and rationalize lipophilicity of simple monomers. Dent Mater. 2005, 21: 591-598. 10.1016\/j.dental.2004.08.004.","journal-title":"Dent Mater"},{"key":"550_CR57","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1021\/ja00299a024","volume":"107","author":"EG Dewar MJSZ","year":"1985","unstructured":"Dewar MJSZ EG, Healy EF: AM1: a New general purpose quantum mechanical molecular model. J Am Chem Soc. 1985, 107: 3902-3909. 10.1021\/ja00299a024.","journal-title":"J Am Chem Soc"},{"key":"550_CR58","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.1021\/cr900238d","volume":"110","author":"AR Katritzky","year":"2010","unstructured":"Katritzky AR, Kuanar M, Slavov S, Hall CD, Karelson M, et al: Quantitative correlation of physical and chemical properties with chemical structure: utility for prediction. Chem Rev. 2010, 110: 5714-5789. 10.1021\/cr900238d.","journal-title":"Chem Rev"},{"key":"550_CR59","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1135\/cccc19991551","volume":"64","author":"MM Karelson","year":"1999","unstructured":"Karelson MM, Uko W, Yilin K, Alan R: QSPR and QSAR models derived using large molecular descriptor spaces. A review of CODESSA applications. Collect Czech Chem Commun. 1999, 64: 1551-1571. 10.1135\/cccc19991551.","journal-title":"Collect Czech Chem Commun"},{"key":"550_CR60","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1016\/S0045-6535(97)10238-7","volume":"36","author":"J Chen","year":"1998","unstructured":"Chen J, Peijnenburg WJGM, Wang L: Using PM3 Hamiltonian, factor analysis and regression analysis in developing quantitative structure\u2013property relationships for photohydrolysis quantum yields of substituted aromatic halides. Chemosphere. 1998, 36: 2833-2853. 10.1016\/S0045-6535(97)10238-7.","journal-title":"Chemosphere"},{"key":"550_CR61","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/qsar.19880070105","volume":"7","author":"D Richard","year":"1988","unstructured":"Richard D, Cramer JDB, Patterson DE, Frank IE: Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quant Struct-Act Relat. 1988, 7: 18-25. 10.1002\/qsar.19880070105.","journal-title":"Quant Struct-Act Relat"},{"key":"550_CR62","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1021\/ci800209k","volume":"48","author":"DA Konovalov","year":"2008","unstructured":"Konovalov DA, Llewellyn LE, Vander Heyden Y, Coomans D: Robust cross-validation of linear regression QSAR models. J Chem Inf Model. 2008, 48: 2081-2094. 10.1021\/ci800209k.","journal-title":"J Chem Inf Model"}],"container-title":["Chemistry Central Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-153X-7-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T12:41:19Z","timestamp":1644237679000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/1752-153X-7-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,4]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["550"],"URL":"https:\/\/doi.org\/10.1186\/1752-153x-7-23","relation":{},"ISSN":["1752-153X"],"issn-type":[{"value":"1752-153X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,4]]},"article-number":"23"}}